• Careers
  • News
Riverpoint Medical
  • Technologies
    • Custom Fibers
    • Surgical Coatings
    • Implantable Materials
    • Finished Devices
    • Needles
  • Markets
    • Sports Medicine
    • Orthopedics
    • Wound Closure
    • Cardiovascular
    • Oncology
    • Ophthalmology
    • Surgical Headlights
  • Capabilities
    • Design & Development
    • Private Labeling
    • Manufacturing
    • Quality & Regulatory
  • About Us
    • Leadership Team
    • Careers
    • Resources
  • Contact
Riverpoint Medical Receives FDA Approvals for  OC Coating Technology of Textile and Fiber

Riverpoint Medical Receives FDA Approvals for OC Coating Technology of Textile and Fiber

by Mark Wellnitz | Oct 27, 2023 | Uncategorized

Riverpoint Medical is thrilled to announce its success in securing its first FDA 510k’s for OC Coating Technology. Osteoconduction, the process by which bone-forming cells migrate across a scaffold and replace it with new bone over time, has long been a pivotal aspect...

Recent Posts

  • Riverpoint Medical Receives FDA Approvals for OC Coating Technology of Textile and Fiber
  • Riverpoint Medical Opens New Manufacturing Facility in Costa Rica
  • Riverpoint expands biologic offering with exclusive license of DSM Biomedical’s proprietary Osteoconductive Coating Technology
  • Riverpoint Medical Exhibiting at AAOS in Las Vegas – March 7-11
  • Riverpoint Medical Exhibiting at MD&M West

Recent Comments

No comments to show.
Riverpoint Medical
© 2022 All Rights Reserved.

Terms of Use  |  Privacy Policy

Corporate Headquarters
825 NE 25th Avenue
Portland, OR 97732 USA

Contact Us

Web Revision: PUB365-04

  • Follow
  • Follow